Refractory atypical teratoid/rhabdoid tumor

Clinical trials for Refractory atypical teratoid/rhabdoid tumor explained in plain language.

Never miss a new study

Get alerted when new Refractory atypical teratoid/rhabdoid tumor trials appear

Sign up with your email to follow new studies for Refractory atypical teratoid/rhabdoid tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New combo therapy targets rare childhood and adult cancers

Disease control Ongoing

This study tests two immunotherapy drugs, tiragolumab and atezolizumab, in children and adults with rare cancers that have come back or not responded to treatment. These cancers lack certain genes (SMARCB1 or SMARCA4), making them hard to treat. The goal is to see if the drug com…

Matched conditions: REFRACTORY ATYPICAL TERATOID/RHABDOID TUMOR

Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

Refractory atypical teratoid/rhabdoid tumor

Get alerted when new Refractory atypical teratoid/rhabdoid tumor trials appear

New combo therapy targets rare childhood and adult cancers